Print

Amicus Therapeutics, Inc. (FOLD) to Present at UBS Annual Global Life Sciences Conference  
9/13/2012 9:21:11 AM

CRANBURY, N.J., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief Executive Officer, will present a corporate overview at the UBS Annual Global Life Sciences Conference in New York, NY on Thursday, September 20 at 10:30 a.m. ET.
//-->